))
Better Health, Brighter Future for Rare with Dan Curran
Manage episode 378782010 series 3349924
Контент предоставлен n-Lorem Foundation (Dr. Stan Crooke, Amy Williford, Kim Butler, Andrew Serrano, Jon Magnuson, and Kira Dineen), N-Lorem Foundation (Dr. Stan Crooke, Amy Williford, Kim Butler, Andrew Serrano, Jon Magnuson, and Kira Dineen). Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией n-Lorem Foundation (Dr. Stan Crooke, Amy Williford, Kim Butler, Andrew Serrano, Jon Magnuson, and Kira Dineen), N-Lorem Foundation (Dr. Stan Crooke, Amy Williford, Kim Butler, Andrew Serrano, Jon Magnuson, and Kira Dineen) или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.
Dr. Daniel Curran leads Takeda’s efforts to unlock innovation and deliver transformative medicines in a variety of rare-disease areas. Dan embraces learning from, collaborating with, and meeting members of the rare disease community in an effort to produce treatments that result in better health and a brighter future for rare.
- 2:02 How rare disease is defined at Takeda
- 4:10 Rare disease units at Takeda
- 5:23 How Takeda economically justifies half of their pipeline being rare disease drugs
- 9:06 The price of rare disease drugs is too high
- 12:15 Why rare disease efforts are often associated with hematology
- 14:57 What Dr. Curran enjoys about leading Takeda's rare genetics and hematology therapeutic unit
- 16:42 Dr. Curran's professional journey
- 20:50 Takeda's choice to support n-Lorem
67 эпизодов
Поделиться
